Emicizumab's Effect on the PTT

Emicizumab's Effect on the PTT
Jan 12, 2021 7:07pm

Here is an informative December 2020 CAP Today article, "Digging Into Drug’s Effect on aPTT-based Assays" [click] by staff writer Amy Carpenter Aquino. The article documents a CAP20 hemophilia therapy session, “aPTT assays in patients on emicizumab are not going to be accurate. And the effect of the drug on our aPTT-based assays can last up to six months following discontinuation of that medication" by Andrew J. Goodwin, MD, clinical pathology division chief and CLIA director, University of Vermont Medical Center and David Unold, MD, associate medical director, transfusion services, University of California Davis Medical Center.

0 Comments

Here is an informative December 2020 CAP Today article, "Digging Into Drug’s Effect on aPTT-based Assays" [click] by staff writer Amy Carpenter Aquino. The article documents a CAP20 hemophilia therapy session, “aPTT assays in patients on emicizumab are not going to be accurate. And the effect of the drug on our aPTT-based assays can last up to six months following discontinuation of that medication" by Andrew J. Goodwin, MD, clinical pathology division chief and CLIA director, University of Vermont Medical Center and David Unold, MD, associate medical director, transfusion services, University of California Davis Medical Center.

Leave A Comment

You must be logged in to Comment - Sign In